VivoSeq
Other

Acute Postoperative Pain

0

Pipeline Programs

3

Active Trials

8

Companies Involved

Acute Postoperative Pain is an early-stage landscape with 0 programs across 8 companies. The most active players are Viatris Specialty LLC, ACADIA Pharmaceuticals Inc., Ensysce Biosciences.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

84/100

Attrition Rate

12/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

25

clinical trials

Completed16 · 64%
Unknown status3 · 12%
Terminated2 · 8%
Recruiting2 · 8%
Withdrawn1 · 4%
Not yet recruiting1 · 4%

Trial Activity

25 trials

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)